INAB.NASDAQIn8bio, INC

Form 4: IN8BIO Director, Corinne Epperly, Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Director Corinne Epperly reports acquisition of stock options in IN8BIO, INC.

Summary

  • Corinne Epperly, a director of IN8BIO, INC. (INAB), filed a Form 4 to report changes in beneficial ownership.
  • The report indicates that Epperly acquired stock options on May 8, 2025, granting her the right to buy 63,150 shares of common stock at an exercise price of $0.17 per share.
  • The options vest in equal monthly installments starting June 8, 2025, with full vesting by the date of the company's next annual meeting of stockholders, contingent upon continued service.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing regarding stock options. It's neutral in sentiment, reflecting standard compensation practices.

Positives

  • The grant of stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule incentivizes continued service and commitment to the company.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, particularly in the biotechnology sector, to align their interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of compensation packages for directors in publicly traded companies.
  • The vesting schedule described is typical, with monthly vesting over a period of time to incentivize continued service.
  • The specific terms of the grant (number of shares, exercise price, vesting schedule) would need to be compared to similar companies in the biotechnology industry to assess its competitiveness.

Stakeholder Impact

  • The stock option grant could potentially dilute existing shareholders if the options are exercised.
  • The grant incentivizes the director to work towards increasing shareholder value.

Key Dates

DateDescription
05/08/2025Date of the stock option transaction.
06/08/2025Commencement date for monthly vesting of the stock options.
05/08/2035Expiration date of the stock options.

Keywords

Form 4, IN8BIO, Stock Options, Beneficial Ownership, Director, INAB, Epperly, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.